Clinical Pharmacology in Psychiatry: From Molecular Studies to Clinical Reality: Psychopharmacology Series, cartea 7
Editat de Svein G. Dahl, Lars F. Gramen Limba Engleză Paperback – 10 dec 2011
Preț: 1264.38 lei
Preț vechi: 1330.93 lei
-5% Nou
Puncte Express: 1897
Preț estimativ în valută:
242.05€ • 251.60$ • 200.69£
242.05€ • 251.60$ • 200.69£
Carte tipărită la comandă
Livrare economică 08-22 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642744327
ISBN-10: 364274432X
Pagini: 344
Ilustrații: XIV, 329 p.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.48 kg
Ediția:Softcover reprint of the original 1st ed. 1989
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Psychopharmacology Series
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 364274432X
Pagini: 344
Ilustrații: XIV, 329 p.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.48 kg
Ediția:Softcover reprint of the original 1st ed. 1989
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Psychopharmacology Series
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
Strategies in Psychotropic Drug Innovation.- Receptor Subtypes and Endogenous Ligands: Rational Tools in the Search for Psychotropic Drugs?.- Histamine H3 Receptors in the Brain: Potent and Selective Ligands..- Targets for Neurotransmitter Receptor Research Using PET Scan: The Neuroleptic Binding Site..- The Potential of Positron-Emission Tomography for Pharmacokinetic and Pharmacodynamic Studies of Neuroleptics..- Neurotransmitter Interactions as a Target of Drug Action..- E-10-Hydroxynortriptyline: Effects and Disposition of a Potential Novel Antidepressant..- Molecular Graphics of Antidepressant Drugs and Metabolites..- Negative Symptoms in Schizophrenia: A Target for New Drug Development..- Clinical Significance of Receptor-Selective Drugs.- Clinical Effects of Selective Serotonin Reuptake Inhibitors..- Effects of Serotonergic Agonists on Neuroendocrine Responses of Rhesus Monkeys and Patients with Depression and Anxiety Disorders..- Theoretical and Practical Implications of a Controlled Trial of an ?2-Adrenoceptor Antagonist in the Treatment of Depression..- Selective Dopamine Dt and D2 Receptor Antagonists..- Animal Pharmacology of Raclopride, a Selective Dopamine D2 Antagonist..- Benzodiazepine Receptor Subtypes and Their Possible Clinical Significance..- Pharmacogenetics in Psychopharmacology.- Genetic Polymorphisms of Drug-Metabolizing Enzymes: Molecular Mechanisms..- Genetic Polymorphism in Drug Oxidation..- The Use of Human Liver Banks in Pharmacogenetic Research..- Inhibitors of the Microsomal Oxidation of Psychotropic Drugs: Selectivity and Clinical Significance..- Pharmacogenetics of Antidepressants..- Pharmacokinetic and Clinical Significance of Genetic Variability in Psychotropic Drug Metabolism..- Inhibition of Desipramine 2-Hydroxylation by Quinidineand Quinine in Rapid and Slow Debrisoquine Hydroxylators..- Debrisoquine Oxidation Phenotype in Psychiatric Patients..- Role of Pharmacogenetics in Drug Development..- Clinical Significance of Pharmacokinetic Variability.- Clinical Implications of the Pharmacokinetics of Tricyclic Antidepressants..- Detection of Populations at Risk Using Drug Monitoring Data..- Hydroxy Metabolites of Tricyclic Antidepressants: Evaluation of Relative Cardiotoxicity..- Therapeutic Drug Monitoring of Tricyclic Antidepressants: A Means of Avoiding Toxicity..- Neuroleptic Drug Levels in Erythrocytes and in Plasma: Implications for Therapeutic Drug Monitoring..- Active Metabolites of Neuroleptics in Plasma and CSF: Implications for Therapeutic Drug Monitoring..- Hydroxyhaloperidol and Clinical Outcome in Schizophrenia..- Plasma Level Monitoring for Maintenance Neuroleptic Therapy..- Perphenazine Serum Levels in Patients on Standard Doses..- Dose-Finding Problems with Psychotropic Drugs.- From Animal Experiments to Clinical Dosing: Some Aspects of Preclinical Development of Antidepressants..- Evaluation of Clinical and Biological Parameters in Healthy Volunteers: More than Pharmacokinetics and Side Effects?.- Dose Finding and Serum Concentrations of Neuroleptics in the Treatment of Schizophrenic Patients..- Post-Marketing Surveillance of Psychotropic Drugs..- List of Participants.